Nadia Merchant
Pediatric Endocrinology · Washington, DCNPI 1245527787
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Biomarin Pharmaceutical Inc. accounts for 68.6% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $28,324, more than ten times the $12 reported in 2019.
Across 94 payments — averaging $523.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$34K
- Catalyst Pharmaceuticals, Inc.$4K
- Novo Nordisk$3K
- Ascendis Pharma Endocrinology Inc$3K
- Kyowa Kirin, Inc.$2K
- Ultragenyx Pharmaceutical Inc.$1K
- plus $1K from 9 others
Across 4 payments — averaging $23,150 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$93K
What the payments were for
- Consulting fees$19,77840%
- Speaking & faculty fees$21,70344%
- Travel & lodging$5,33811%
- Food & beverage$2,4155%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 56 | $33,794 |
| Catalyst Pharmaceuticals, Inc. | 10 | $4,345 |
| Novo Nordisk | 6 | $3,442 |
| Ascendis Pharma Endocrinology Inc | 1 | $3,215 |
| Kyowa Kirin, Inc. | 6 | $1,672 |
| Ultragenyx Pharmaceutical Inc. | 2 | $1,324 |
| AstraZeneca | 1 | $900 |
| Pfizer | 2 | $143 |
| Dexcom, Inc. | 2 | $139 |
| Sanofi-aventis U.S. LLC | 1 | $116 |
| AbbVie | 2 | $51 |
| BETA Bionics, Inc. | 2 | $33 |
| Tolmar, Inc. | 1 | $28 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| Companion Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$17,634
- Sogroya$3,255
- CRYSVITA$2,934
- Palynziq$2,240
- AGAMREE$1,318
- Strensiq$900
- NGENLA$126
- DEXCOM G7 GSS (161)$101
How this compares
$49,234 in reported general payments places this provider in the 85th percentile of 20 pediatric endocrinology providers in District of Columbia.
See all pediatric endocrinology providers in District of Columbia →
Other pediatric endocrinology in Washington
- Shideh MajidiWashington$88K
- Fran CogenWashington$63K
- Abby MeyersWashington$22K
- Roopa Kanakatti ShankarWashington$18K
- Doris EstradaWashington$10K
- Gail Nunlee-BlandWashington$10K
- Paul KaplowitzWashington$7K
- Alison BoyceWashington$6K
- Jody GrundmanWashington$4K
- Nicolas CuttrissWashington$406
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.